glp 1 and steroids Mechanisms of action of GLP-1RA GLP-1 and Inflammation: How These

(And Why Its Not Just Weight Gain) Lipedema is a chronic condition affecting mainly women, characterized by (Cifarelli, 2025): Disproportionate fat accumulation (typically in the legs and sometimes arms) Inflammation and fibrosis Impaired microvascular and lymphatic circulation Resistance to traditional weight loss approaches Recent research shows that lipedema is not simply a fat storage issueit is a complex condition involving: Chronic inflammation Fibrosis (thickening and stiffening of tissue) Hormonal influences (especially estrogen signaling) Microvascular and lymphatic changes Metabolic dysfunction This helps explain why conventional approaches like calorie restriction or even bariatric surgery may fail to meaningfully change lipedema tissue (Viana et al., 2025)

K.RolkaD.et al

Resistance training was emphasized as the most critical intervention more important than any supplement for preserving lean mass during pharmacotherapy-induced weight loss

Behaviour rather than trend The long-term outlook depends partly on how widely these medications spread

[103] conducted a prospective observational study evaluating 30 RA patients with obesity and T2DM treated with GLP-1 RAs for 6 months, without concomitant conventional or biologic disease-modifying anti-rheumatic drugs (DMARDs)

If you are on both levothyroxine and oral contraceptives, the timing considerations multiply